331.23
Madrigal Pharmaceuticals Inc stock is traded at $331.23, with a volume of 324.68K.
It is up +1.02% in the last 24 hours and down -2.94% over the past month.
See More
Previous Close:
$327.87
Open:
$317.62
24h Volume:
324.68K
Relative Volume:
0.90
Market Cap:
$7.45B
Revenue:
-
Net Income/Loss:
$-518.67M
P/E Ratio:
-13.19
EPS:
-25.12
Net Cash Flow:
$-438.32M
1W Performance:
-4.38%
1M Performance:
-2.94%
6M Performance:
+56.08%
1Y Performance:
+24.04%
Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile
Name
Madrigal Pharmaceuticals Inc
Sector
Industry
Phone
404-380-9263
Address
200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA
Compare MDGL with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
MDGL
Madrigal Pharmaceuticals Inc
|
331.23 | 7.45B | 0 | -518.67M | -438.32M | -25.12 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Madrigal Pharmaceuticals Inc Stock (MDGL) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-28-25 | Upgrade | B. Riley Securities | Neutral → Buy |
Feb-27-25 | Reiterated | H.C. Wainwright | Buy |
Jun-28-24 | Initiated | Cantor Fitzgerald | Neutral |
Jun-11-24 | Initiated | Wolfe Research | Outperform |
Apr-22-24 | Initiated | BofA Securities | Underperform |
Mar-15-24 | Upgrade | B. Riley Securities | Sell → Neutral |
Mar-06-24 | Initiated | Citigroup | Buy |
Feb-26-24 | Downgrade | B. Riley Securities | Neutral → Sell |
Dec-20-22 | Reiterated | Oppenheimer | Outperform |
Dec-19-22 | Reiterated | H.C. Wainwright | Buy |
Dec-19-22 | Reiterated | Piper Sandler | Overweight |
Dec-19-22 | Upgrade | Raymond James | Underperform → Mkt Perform |
Jul-08-22 | Downgrade | B. Riley Securities | Buy → Neutral |
Oct-07-21 | Initiated | Jefferies | Buy |
Aug-06-21 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
May-20-21 | Resumed | Goldman | Buy |
Nov-24-20 | Resumed | Evercore ISI | Outperform |
Nov-06-20 | Reiterated | H.C. Wainwright | Buy |
Jul-31-20 | Initiated | Piper Sandler | Overweight |
Jun-05-20 | Initiated | BMO Capital Markets | Market Perform |
May-05-20 | Initiated | Chardan Capital Markets | Buy |
Jan-30-20 | Initiated | Canaccord Genuity | Buy |
Jan-09-20 | Upgrade | UBS | Neutral → Buy |
Nov-07-19 | Reiterated | H.C. Wainwright | Buy |
Jun-25-19 | Initiated | Stifel | Hold |
Jun-10-19 | Upgrade | B. Riley FBR | Neutral → Buy |
Feb-28-19 | Reiterated | H.C. Wainwright | Buy |
Feb-22-19 | Initiated | SVB Leerink | Outperform |
Jan-23-19 | Initiated | UBS | Neutral |
Dec-14-18 | Initiated | Wolfe Research | Outperform |
Dec-12-18 | Initiated | B. Riley FBR | Neutral |
Nov-19-18 | Downgrade | Raymond James | Mkt Perform → Underperform |
Nov-16-18 | Upgrade | Evercore ISI | In-line → Outperform |
Sep-04-18 | Initiated | Citigroup | Buy |
Aug-06-18 | Downgrade | Goldman | Buy → Neutral |
Jun-28-18 | Initiated | Raymond James | Mkt Perform |
View All
Madrigal Pharmaceuticals Inc Stock (MDGL) Latest News
Is Madrigal Pharmaceuticals (MDGL) The Most Expensive Stock Insiders Are Dumping In March? - Yahoo Finance
Madrigal (MDGL) Up 0.5% Since Last Earnings Report: Can It Continue? - Nasdaq
Analysts Expect Breakeven For Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Before Long - simplywall.st
(MDGL) On The My Stocks Page - Stock Traders Daily
EU health regulator clears use of AI tool in fatty liver disease trials - Reuters
Madrigal Pharmaceuticals (MDGL): Among the Best Biotech Stocks to Buy According to Billionaires - Insider Monkey
15 Best Biotech Stocks to Buy According to Billionaires - Insider Monkey
Madrigal Pharmaceuticals Announces Changes to Board of Directors - MSN
Madrigal Pharmaceuticals SVP and CFO sells stock for $83,344 - Investing.com India
Madrigal Pharmaceuticals’ SWOT analysis: Rezdiffra success drives stock potential By Investing.com - Investing.com Australia
Madrigal Pharmaceuticals’ SWOT analysis: Rezdiffra success drives stock potential - Investing.com India
Madrigal Pharmaceuticals SVP and CFO sells stock for $83,344 By Investing.com - Investing.com Australia
Victory Capital Management Inc. Has $21.80 Million Stock Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - Defense World
Bank of New York Mellon Corp Lowers Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - Defense World
Madrigal Pharmaceuticals appoints new board member By Investing.com - Investing.com Australia
How the (MDGL) price action is used to our Advantage - Stock Traders Daily
Madrigal Pharmaceuticals Expands Board with New Appointment - TipRanks
Madrigal appoints Jacqualyn Fouse to its board -March 11, 2025 at 09:36 am EDT - Marketscreener.com
Madrigal Appoints Jacqualyn A. Fouse, Ph.D. To Board - citybiz
Madrigal Pharmaceuticals appoints new board member - Investing.com India
Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors - The Manila Times
Why Madrigal Pharmaceuticals (MDGL) Stock is Rising Today - GuruFocus.com
Robert E. Waltermire Sells 14,113 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock - Defense World
Insider Sale at Madrigal Pharmaceuticals Inc (MDGL): Senior VP, - GuruFocus.com
Madrigal Pharmaceuticals Exec Cashes Out in Multi-Million Dollar Stock Sale! - TipRanks
Madrigal Pharmaceuticals’ senior VP sells $4.8 million in stock By Investing.com - Investing.com Canada
Madrigal Pharmaceuticals’ senior VP sells $4.8 million in stock - Investing.com India
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Holdings Reduced by Principal Financial Group Inc. - Defense World
Madrigal Pharmaceuticals CFO Mardi sells $637,247 in stock - Investing.com India
Madrigal Pharmaceuticals exec sells $418,488 in stock By Investing.com - Investing.com South Africa
Madrigal Pharmaceuticals exec sells $418,488 in stock - Investing.com
Madrigal Pharmaceuticals (NASDAQ:MDGL) Trading Down 6.8% on Insider Selling - Defense World
B. Riley Analysts Increase Earnings Estimates for MDGL - Defense World
Sanctuary Advisors LLC Acquires 62 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - Defense World
HC Wainwright Issues Negative Estimate for MDGL Earnings - Defense World
Madrigal Pharmaceuticals Reports Strong 2024 Growth Fueled by Rezdiffra Launch - MSN
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives $351.67 Consensus PT from Analysts - MarketBeat
New York State Common Retirement Fund Sells 5,630 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Citigroup Boosts Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $469.00 - Defense World
Madrigal Pharmaceuticals (NASDAQ:MDGL) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
Madrigal Pharmaceuticals director Kenneth Bate sells $7.1m in stock By Investing.com - Investing.com Australia
(MDGL) Trading Report - Stock Traders Daily
Madrigal Pharmaceuticals director Kenneth Bate sells $7.1m in stock - Investing.com
Madrigal Pharmaceuticals Inc Stock (MDGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):